These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37314625)

  • 1. Dasatinib-related left ventricular dysfunction in a patient with chronic myelogenous leukemia.
    Kawanami Y; Yamaguchi K; Yamasaki S; Kagawa Y; Sato H; Watanabe N; Endo A; Yoshitomi H; Tanabe K
    J Echocardiogr; 2024 Jun; 22(2):99-101. PubMed ID: 37314625
    [No Abstract]   [Full Text] [Related]  

  • 2. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors.
    Karakulak UN; Aladag E; Hekimsoy V; Sahiner ML; Kaya EB; Ozer N; Aksu S; Demiroglu H; Goker H; Buyukasik Y; Ozcebe O; Sayinalp N; Haznedaroglu IC
    Cardiovasc Toxicol; 2021 Mar; 21(3):216-223. PubMed ID: 33068232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib-induced loss of eyebrows.
    Naithani R
    Br J Haematol; 2017 Nov; 179(3):362. PubMed ID: 28737227
    [No Abstract]   [Full Text] [Related]  

  • 4. Is dasatinib-related pulmonary hypertension a clinical concern?
    Szmit S
    Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
    McGrath K; Stein B; Kalhagen L; Leighton L
    Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
    [No Abstract]   [Full Text] [Related]  

  • 6. Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia.
    Yim E; Choi YG; Nam YJ; Lee J; Kim JA
    Korean J Intern Med; 2018 Mar; 33(2):446-448. PubMed ID: 26961484
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypopigmentation of the Skin and Hair Associated with Dasatinib Therapy.
    Sharma V; Bagrodia V
    Turk J Haematol; 2024 May; 41(2):116-117. PubMed ID: 37698254
    [No Abstract]   [Full Text] [Related]  

  • 8. Change of right ventricular systolic pressure can indicate dasatinib-induced pulmonary arterial hypertension in chronic myeloid leukemia.
    Lee SE; Hyun Kong J; Kim SH; Jang EJ; Chung NG; Cho B; Joong Oh S; Jung HE; Youn HJ; Chung WB; Kim DW
    Cancer Med; 2021 Mar; 10(5):1515-1524. PubMed ID: 33590711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into dasatinib use and outcomes in real-world patients with chronic myeloid leukemia.
    Adattini JA; Gross AS; Doo NW; McLachlan AJ
    Haematologica; 2023 Aug; 108(8):2224-2228. PubMed ID: 36655426
    [No Abstract]   [Full Text] [Related]  

  • 10. Sweet syndrome in a patient with chronic myelogenous leukemia under dasatinib treatment.
    Matsuda T; Ueda-Hayakawa I; Kambe N; Fujita S; Okamoto H
    J Dermatol; 2019 Sep; 46(9):e317-e318. PubMed ID: 30932238
    [No Abstract]   [Full Text] [Related]  

  • 11. Interstitial pneumonitis associated with dasatinib: two case reports and literature review.
    Ito Y; Tanigawa M; Iwamoto K; Nigi A; Itani H; Kondo S; Tokui T; Usui E; Tamaki S
    Respir Investig; 2019 Sep; 57(5):506-509. PubMed ID: 31311724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib-induced pulmonary hypertension in chronic myelogenous leukaemia.
    Yun S; Anwer F; Vincelette ND
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24810451
    [No Abstract]   [Full Text] [Related]  

  • 13. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
    Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
    BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib.
    Haddad FG; Nasnas C; Sasaki K; Paul S; Issa GC; Rausch C; Jabbour E; Kantarjian H
    Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):484-487. PubMed ID: 38503634
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.
    Kostos L; Burbury K; Srivastava G; Prince HM
    Platelets; 2015; 26(8):809-11. PubMed ID: 26029798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia.
    Aoyama R; Ishikawa J; Harada K
    J Cardiol; 2020 Feb; 75(2):203-207. PubMed ID: 31416783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
    Wang HC; Lee CS; Liu TC
    Kaohsiung J Med Sci; 2015 Mar; 31(3):165-6. PubMed ID: 25744241
    [No Abstract]   [Full Text] [Related]  

  • 18. Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia.
    Inoue H; Taji H; Yamada K; Iriyama C; Saito T; Kato H; Yanada M; Yamamoto K; Matsukawa N
    Intern Med; 2020 Oct; 59(19):2419-2421. PubMed ID: 32611965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Desensitization to Oral Dasatinib in Immediate Hypersensitivity Reaction.
    Ruano-Zaragoza M; Torrent-Rodríguez A; Araujo-Sanchez G; Ribó P; Loli-Ausejo D; Solis K; Sánchez-Fernández MC; Bolaños J; Bolós U; López C; Ruiz S; Pascal M; Bartra J; Muñoz-Cano R
    J Investig Allergol Clin Immunol; 2024 Jul; 34(4):274-276. PubMed ID: 38131221
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary hypertension in patients with chronic myeloid leukemia.
    Song IC; Yeon SH; Lee MW; Ryu H; Lee HJ; Yun HJ; Sun BJ; Park JH; Jeong JO; Jo DY
    Medicine (Baltimore); 2021 Aug; 100(33):e26975. PubMed ID: 34414970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.